Lupin launches generic Brivaracetam oral solution in US to treat epilepsy
Brivaracetam is the bioequivalent to Briviact Oral Solution, 10 mg/mL, of UCB
Brivaracetam is the bioequivalent to Briviact Oral Solution, 10 mg/mL, of UCB
Sodium Phosphates Injection is indicated as a source of phosphorus, for addition to large volume intravenous fluids, to prevent or correct hypophosphatemia in patients with restricted or no oral intake
Liraglutide is a drug-device combination formulation used in the treatment of chronic weight management
The collaboration merges biomodal’s 5-base and 6-base sequencing solutions, duet +modC and duet evoC
The alliance directly links VivaMed’s computational drug hypotheses with Syngene’s preclinical development capabilities
40+ most innovative startups with disruptive contributions across MedTech, Medical Devices, BioPharma, Cell and Gene Therapy, AI and ML, Nutraceuticals, and Biomarkers exhibited their cutting-edge solutions
Each company will share operational data with Evinova, feeding the platform’s AI engines to provide benchmarks and actionable insights, aiming to speed up trials while maintaining top-tier patient care
This transaction fundamentally strengthens Scinai's CDMO platform
Subscribe To Our Newsletter & Stay Updated